Scientists grow human blood vessels in lab for the first time
Scientists at the University of British Columbia have grown a pair human blood vessels for the first time.
Advertisement
Recommended Stories
$433 Billion Gone! One Stock Loses More Value Than Tesla
Tesla's loss of $328.3 billion this year in stock value certainly hurts. But it's only the second-largest market value loss in the S&P 500.
Investor's Business Daily•Mark Zuckerberg got $24.4 million in ‘other compensation’ in 2023—but Meta also treated staff well, with the median employee making $379,000
On paper, Mark Zuckerberg is Meta’s lowest-paid employee, with a $1 dollar salary and no bonus.
Fortune•Analysts reset Microsoft stock price targets ahead of highly anticipated earnings
Microsoft, which overtook Apple as the world's most valuable company earlier this year, is looking to cement its AI market leadership.
TheStreet•China's Temu Takes Over 17% Of US Market Share, Cutting Jobs From American Amazon And Decimating Small Businesses
With rising inflation, American consumers are increasingly turning to the Chinese e-commerce platform Temu for their shopping needs. With its enticing tagline “Shop like a billionaire,” Temu has captured 17% of the U.S. market share, posing a challenge to traditional American retailers such as Amazon.com Inc., Dollar Tree Inc. and Five Below Inc. The rise highlights the lucrative and disruptive nature of startups. Owned and operated by PDD Holdings Inc. (NASDAQ:PDD), Temu offers a wide range of
Benzinga•Analysts reboot Amazon stock price target ahead of earnings
This is what could happen next to Amazon shares.
TheStreet•Bitcoin Just Did Something It Has Only Done 3 Times Before. The Cryptocurrency Usually Does This Next.
Bitcoin block subsidies were recently reduced by half for the fourth time in history, and halving events have always led to significant price appreciation.
Motley Fool•One Member of Congress Is Going Against the Grain and Selling This Skyrocketing Stock-Split Stock
One of Capitol Hill's most-active stock traders is sending a company with well-defined competitive advantages -- that also happens to be on the verge of its first-ever stock split -- to the chopping block.
Motley Fool•Suze Orman Decided To Drop Homeowners Insurance After An Outrageous Quote: '$28,000 For A 2,100-Square-Foot Condo. Are You Kidding Me?'
Finance expert Suze Orman has voiced concerns about the impact of climate change on property insurance costs, asserting it could threaten the American dream of homeownership. Orman, 72, faced a $28,000 annual insurance quote for her Florida oceanside condo, leading her to forego coverage entirely. She highlights a troubling trend where soaring insurance costs driven by frequent and severe weather events may deter Americans from buying homes. Don't Miss: For many first-time buyers, a house is abo
Benzinga•This Artificial Intelligence (AI) Stock Could Soar 70%, According to Wall Street. Time to Buy?
This company's exciting technology is protected by more than 100 patents.
Motley Fool•Intel Earnings Day Is Here. Better PC Demand Could Provide a Boost.
Intel stock bulls will need to remain patient, with multiple quarters to go before the chip company gains traction for a bet-the-company push to compete with Taiwan Semiconductor Manufacturing and Samsung in the chip-manufacturing business. Meanwhile, Intel’s first-quarter-earnings report, due after the close of trading Thursday, could show signs of improving demand from the PC segment. Citi analyst Christopher Danely, while maintaining a Neutral rating on Intel shares, recently launched an “upside catalyst watch” on the stock, which is down 32% year to date, largely due to recent disclosures of larger-than-expected losses on the company’s foundry business.
Barrons.com•